DIAGNOSTIC AND THERAPEUTIC BENEFITS OF BIOMARK’S CANCER MARKER FEATURED IN TWO POSTER PRESENTATIONS AT THE CANADIAN CANCER RESEARCH CONFERENCE

diagnostic and therapeutic benefits of biomark cancer marker - canadian cancer research conference

Diagnostic and Therapeutic Benefits of BioMark’s Cancer Marker Featured In Two Poster Presentations At The Canadian Cancer Research Conference Vancouver, British Columbia – (November 8th, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased […]